ArticleFrontiers in oncology2024

Disitamab vedotin (RC48) long-term regimen in a post-nephroureterectomy patient with metastases: a case report.

Weiping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.